CellPro Inc., which until now has had the cell separation market pretty much to itself, will begin to face competition from Baxter Healthcare Corp., which last week announced European regulatory approval for its Isolex 300 Magnetic Cell Separator system.

Isolex received the CE Mark of conformity, which allows the company to market the stem cell separation device in all the countries of the European Union.